Company: IMG
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001493152-25-021912
Chunk: 0

Company: CIMG Inc.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events.

Affirmation
of Compliance with Nasdaq Shareholders Equity Requirement

As
set forth in the pro forma balance sheet attached hereto as Exhibit 99.1, as a result of the below-described transactions, CIMG Inc.
(the “ Company

Following
a hearing held on August 14, 2025, the Nasdaq Hearings Panel issued a decision on September 2, 2025, granting the Company’s request
to continue listing on The Nasdaq Stock Market, subject to the Company’s timely satisfaction of specified conditions, including
(i) filing all required periodic reports and (ii) demonstrating compliance with the Nasdaq Listing Rule 5550(b)(1) (the “ Equity
Requirement Exchange
Act

In
its effort to regain compliance with the Equity Requirement and subsequent to the quarter ended June 30, 2025 and through September 30,
2025, the Company completed the following unregistered issuances of equity securities, which collectively increased shareholders’
equity to approximately US $49.52 million:

  On                                                                                                                                        
  August 21, 2025, the Company entered into a Convertible Note Purchase Agreement with certain non-U. S. investors for an aggregate         
  principal amount of US $4,000,000. The notes bear interest at 7% per annum, mature on August 31, 2026, and are convertible into shares    
  of the Company’s common stock, par value $0.00001 per share (the “ Common Stock ”) at US $0.24 per share.                                 
  Holders converted their notes in full, and the Company issued an aggregate 8,333,333 shares of Common Stock on September 9, 2025          
  (the remaining conversion of 8,333,333 shares of Common Stock occurred in October 2025, as described below); and                          
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  On                                                                                                                                        

Subsequent
Events After September 30, 2025 (Not Reflected in September 30, 2025 Balance Sheet)

After
September 30, 2025, the Company completed additional equity issuances, including (i) the remaining 71,900,000 shares of Common Stock
issued on October 29, 2025, pursuant to the Securities Purchase Agreement dated August 25, 2025, (ii) the remaining US $4